Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~6.67 mg/mL total) Route: Subcutaneous injection | Frequency: Once daily For 10-unit (0.10 mL) administrations during Weeks 14, consider using 30- or 50-unit insulin syringes for improved readability
W.1997Sulfation and sulfotransferases 5: the importance of 3-phosphoadenosine 5-phosphosulfate (PAPS) in the regulation of sulfation.116(May 1997),404418,0892-6638 64
In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
JACC Basic Transl Sci (2018) 3(6):84457
